Astrotech Corporation (ASTC)
- Previous Close
5.75 - Open
5.85 - Bid --
- Ask --
- Day's Range
5.80 - 5.85 - 52 Week Range
5.74 - 12.29 - Volume
1,101 - Avg. Volume
3,116 - Market Cap (intraday)
9.87M - Beta (5Y Monthly) 0.22
- PE Ratio (TTM)
-- - EPS (TTM)
-8.18 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
www.astrotechcorp.comRecent News: ASTC
View MorePerformance Overview: ASTC
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ASTC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ASTC
View MoreValuation Measures
Market Cap
9.84M
Enterprise Value
-14.71M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
22.64
Price/Book (mrq)
0.35
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-25.10%
Return on Equity (ttm)
-39.20%
Revenue (ttm)
419k
Net Income Avi to Common (ttm)
-13.4M
Diluted EPS (ttm)
-8.18
Balance Sheet and Cash Flow
Total Cash (mrq)
24.69M
Total Debt/Equity (mrq)
0.50%
Levered Free Cash Flow (ttm)
-8.02M